The Science Is Finally Catching Up With Spoon Theory
For years, "pace yourself" was dismissed as anecdote. Now there are biomarkers.
If you live with a chronic illness, you already know the crash that comes a day after doing too much. What's new is that research is now able to measure it, name the mechanisms behind it, and, in one major case, formally reverse decades of bad medical advice built on ignoring it.
What is going on
Post-Exertional Malaise Now Has a Biomarker
The "payback" after overexertion isn’t in your head. Repeat exercise testing can now show it.
Two-day cardiopulmonary exercise testing, where patients are tested, then retested a day later, has repeatedly shown something striking in ME/CFS and long COVID: performance that holds up reasonably well on day one, then drops sharply on day two, in a pattern healthy control groups don’t show. That gap is an objective, measurable signature of post-exertional malaise (PEM), the exact "payback" spoonies have described for years without being believed.
→PEM was always real. It just took retesting the body a day later for the evidence to show up.
Long COVID Put Dysautonomia on the Map
POTS went from a condition few clinicians had heard of to one that reshaped how long COVID is understood.
A meaningful share of long COVID patients have gone on to be diagnosed with POTS (postural orthostatic tachycardia syndrome) or other forms of dysautonomia: a nervous system that mismanages heart rate, blood pressure, and blood flow on standing. The scale of long COVID has done what decades of smaller case studies couldn’t: it’s pushed autonomic dysfunction into mainstream clinical awareness.
→It took a pandemic-scale patient population to make an old, under-recognised condition visible.
The EDS, POTS and MCAS Triad
Hypermobility, an erratic nervous system, and allergic-type reactions keep showing up together, and often alongside neurodivergence.
Clinicians increasingly describe a recurring cluster: hypermobile Ehlers-Danlos syndrome (or hypermobility spectrum disorder), POTS, and mast cell activation syndrome (MCAS), a triad that frequently co-occurs. Research on joint hypermobility has also found a stronger overlap than expected with anxiety and with autistic and ADHD traits, suggesting a shared connective-tissue-and-nervous-system thread running under conditions that used to be diagnosed, and treated, in total isolation from each other.
→These weren’t three unrelated diagnoses. They were pieces of one system finally being read together.
Fibromyalgia Pain Is a Volume Problem, Not a Tissue Problem
Brain imaging keeps finding the same thing: normal tissue, amplified signal.
Pain research on fibromyalgia points consistently to central sensitisation: the central nervous system turning up the volume on pain and sensory signals, rather than damage in the muscles or joints themselves. Imaging studies have found measurable differences in how fibromyalgia patients’ brains process pain signals, even when the tissue being tested shows nothing abnormal. That mismatch, normal tissue and real pain, is exactly what patients were disbelieved over for years.
→The tissue was never the problem. The volume dial was.
Pacing Beat "Push Through It," Officially
A major clinical guideline reversed its own advice after the evidence caught up with what patients had said all along.
For years, some ME/CFS patients were formally advised to use graded exercise therapy: steadily increasing activity regardless of symptoms. Following mounting evidence that this approach could worsen PEM and cause lasting harm, the UK’s national clinical guideline body revised its recommendations, dropping graded exercise therapy in favour of pacing: staying within your energy envelope instead of pushing past it. It was a rare, direct instance of "listen to the patients describing their own bodies" winning out over "push through it" as official medical guidance.
→Pacing wasn’t a coping mechanism people invented to feel in control. It was the correct medical answer the whole time.
What to do about it
So what helps?
Spoon theory was never a metaphor for the weak-willed. It was an early, accurate model.
The throughline across PEM, dysautonomia, the EDS-POTS-MCAS triad, and central sensitisation research is that these are measurable, physiological processes, not exaggeration, not deconditioning, not something a positive attitude fixes. Energy limits are real limits. Pacing within them isn't giving up. It's the evidence-based response to a body that keeps the receipts even when it doesn't show up on a standard test.
The reframe
"If I just push through, I’ll build up my tolerance"
"Staying inside my energy envelope is what the evidence says actually works"
Tracking energy like a budget, not a test of willpower, is now something clinical guidance itself recommends.
A crash a day (or more) after overexertion is a documented pattern, not proof you’re unfit or exaggerating.
Symptoms that don’t show up on standard bloodwork can still have a measurable physiological cause.
The business case
PEM biomarkers, dysautonomia research, the EDS-POTS-MCAS triad, central sensitisation imaging, and the reversal of graded exercise guidance all point the same direction: the chronic illness community's lived knowledge was ahead of the research, not disconnected from it.
None of this makes managing a chronic illness easy. But it does mean the spoons were never an excuse. They were an early, remarkably accurate model of something medicine is only now able to measure.